Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.
Cell Death Dis. 2012 Aug 23;3(8):e376. doi: 10.1038/cddis.2012.122.
Falcarindiol (FAD) is a natural polyyne with various beneficial biological activities. We show here that FAD preferentially kills colon cancer cells but not normal colon epithelial cells. Furthermore, FAD inhibits tumor growth in a xenograft tumor model and exhibits strong synergistic killing of cancer cells with 5-fluorouracil, an approved cancer chemotherapeutic drug. We demonstrate that FAD-induced cell death is mediated by induction of endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR). Decreasing the level of ER stress, either by overexpressing the ER chaperone protein glucose-regulated protein 78 (GRP78) or by knockout of components of the UPR pathway, reduces FAD-induced apoptosis. In contrast, increasing the level of ER stress by knocking down GRP78 potentiates FAD-induced apoptosis. Finally, FAD-induced ER stress and apoptosis is correlated with the accumulation of ubiquitinated proteins, suggesting that FAD functions at least in part by interfering with proteasome function, leading to the accumulation of unfolded protein and induction of ER stress. Consistent with this, inhibition of protein synthesis by cycloheximide significantly decreases the accumulation of ubiquitinated proteins and blocks FAD-induced ER stress and cell death. Taken together, our study shows that FAD is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.
法卡林二醇(FAD)是一种具有多种有益生物活性的天然聚炔。我们在此表明,FAD 优先杀死结肠癌细胞,但不杀死正常结肠上皮细胞。此外,FAD 在异种移植肿瘤模型中抑制肿瘤生长,并与批准的癌症化疗药物 5-氟尿嘧啶表现出强烈的协同杀伤癌细胞作用。我们证明,FAD 诱导的细胞死亡是通过诱导内质网(ER)应激和未折叠蛋白反应(UPR)的激活来介导的。无论是通过过表达 ER 伴侣蛋白葡萄糖调节蛋白 78(GRP78)还是敲除 UPR 途径的成分来降低 ER 应激水平,都可以减少 FAD 诱导的细胞凋亡。相比之下,通过敲低 GRP78 增加 ER 应激水平会增强 FAD 诱导的细胞凋亡。最后,FAD 诱导的 ER 应激和细胞凋亡与泛素化蛋白的积累相关,表明 FAD 的作用至少部分是通过干扰蛋白酶体功能,导致未折叠蛋白的积累和 ER 应激的诱导。与此一致,通过环己酰亚胺抑制蛋白质合成会显著减少泛素化蛋白的积累,并阻断 FAD 诱导的 ER 应激和细胞死亡。综上所述,我们的研究表明,FAD 是一种潜在的新型抗癌药物,通过诱导 ER 应激和细胞凋亡发挥其活性。